Regenxbio News

Regenxbio | 4: Statement of changes in beneficial ownership of securities-Officer Mills Kenneth T.

May 16 17:12 ET

Regenxbio | 144: Notice of proposed sale of securities pursuant to Rule 144

May 14 16:29 ET

Regenxbio | 10-Q: Quarterly report

May 8 16:23 ET

Regenxbio | 8-K: REGENXBIO Reports First Quarter 2024 Financial Results and Recent Operational Highlights

May 8 16:19 ET

Regenxbio | 4: Statement of changes in beneficial ownership of securities-Officer Mills Kenneth T.

Apr 17 17:10 ET

Regenxbio | ARS: Annual Report to Security Holders

Apr 4 16:22 ET

Regenxbio | DEFA14A: Others

Apr 4 16:18 ET

Regenxbio | DEF 14A: Definitive information statements

Apr 4 16:17 ET

Regenxbio | 4: Statement of changes in beneficial ownership of securities-Officer Vasista Vittal

Mar 21 17:22 ET

Regenxbio | 4: Statement of changes in beneficial ownership of securities-Officer Mills Kenneth T.

Mar 18 17:06 ET

Regenxbio | 8-K: Current report

Mar 11 08:01 ET

Regenxbio | 424B5: Prospectus

Mar 8 06:14 ET

Regenxbio | 4: Statement of changes in beneficial ownership of securities-Officer PAKOLA STEVE

Mar 7 18:10 ET

Regenxbio | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Mar 7 06:09 ET

Regenxbio | 424B5: Prospectus

Mar 6 16:26 ET

Regenxbio | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 5 16:32 ET

Regenxbio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 27 16:59 ET

Regenxbio | 10-K: Annual report

Feb 27 16:22 ET

Regenxbio | 8-K: REGENXBIO Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights

Feb 27 16:18 ET

Regenxbio | 4: Statement of changes in beneficial ownership of securities-Officer Mills Kenneth T.

Feb 16 18:32 ET